Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

Philip Morris International Inc. (PM) saw its stock rise on Wednesday following positive news regarding the U.S. Food and ...

Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...

The FDA approved nicotine pouches from ZYN, deeming them safer than cigarettes. Thursday’s decision allows ZYN to remain on ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

Federal health officials authorize Zyn nicotine pouches, citing potential to help adult smokers cut back or quit.

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...

The agency found Zyn’s benefit as a safer alternative for adult cigarette smokers outweighs its risk to young people.